Lucia Carril Ajuria - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Lucia Carril Ajuria

This paper was not found in any repository, but could be made available legally by the author.

2022 Rafee Talukder

ORCID

, Dimitrios Makrakis, Genevieve Ihsiu Lin, Leonidas N. Diamantopoulos, Scott Dawsey, Shilpa Gupta, Lucia Carril-Ajuria

ORCID

, Daniel Castellano, Ivan de Kouchkovsky, Tanya Jindal

ORCID

, Vadim S. and Park Joseph J. Koshkin, Joseph J. Park

ORCID

, Ajjai Alva, Mehmet A. Bilen, Stewart Tyler F. and 40 other authors

Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma

Upload

This paper is made freely available by the publisher.

Lucia Carril-Ajuria

ORCID

, Aude Desnoyer, Maxime Meylan, Cécile Dalban, Marie Naigeon, Lydie Cassard, Yann Vano, Nathalie Rioux-Leclercq, Salem Chouaib, Benoit Beuselinck, Sylvie Chabaud, Janice Barros-Monteiro, Antoine Bougoüin, Guillaume Lacroix, Irelka Colina-Moreno and 8 other authors

Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study

Download from doi.org

This paper is made freely available by the publisher.

Ray Manneh, Mauricio Lema, Lucía Carril-Ajuria

ORCID

ORCID

, Susan Martínez, Daniel Castellano, Guillermo de Velasco

Immune Checkpoint Inhibitor Combination Therapy versus Sunitinib as First-Line Treatment for Favorable-IMDC-Risk Advanced Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2021 Francisco Zambrana, Lucia Carril-Ajuria

ORCID

, Alfonso Gómez de Liaño, Nieves Martinez Chanza, Ray Manneh

ORCID

, Daniel Castellano, Guillermo de Velasco

Complete response and renal cell carcinoma in the immunotherapy era: The paradox of good news

Upload

This paper was not found in any repository, but could be made available legally by the author.

Lucia Carril-Ajuria

ORCID

, Emeline Colomba, Luigi Cerbone

ORCID

, Carmen Romero-Ferreiro

ORCID

, Laurence Crouzet, Brigitte Laguerre, Constance Thibault, Cécile Vicier, Guillermo de Velasco, Aude Fléchon, Carolina Saldana, Patrick R. Benusiglio

ORCID

, Brigitte Bressac-De Paillerets, Marine Guillaud-Bataille, Pauline Gaignard

ORCID

and 5 other authors

Response to systemic therapy in fumarate hydratase–deficient renal cell carcinoma

Upload

This paper was not found in any repository, but could be made available legally by the author.

2020 Lucia Carril-Ajuria

ORCID

, David Lora, Alberto Carretero-González, Maricruz Martín-Soberón, Patricia Rioja-Viera

ORCID

, Daniel Castellano, Guillermo de Velasco

Systemic analysis and review of nivolumab-ipilimumab combination as a rescue strategy for Renal Cell Carcinoma after treatment with anti-PD1/PD-L1 therapy

Upload

Missing publications? Search for publications with a matching author name.